RAJESH SHROTRIYA, M.D.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

GT Biopharma, Inc.

Filing Date Source Excerpt
2022-04-29 Rajesh Shrotriya, M.D. (2) 2021 178,671 178,671
2022-08-17 Rajesh Shrotriya, M.D.
2023-05-01 Rajesh Shrotriya, M.D. - Director
2023-11-06 Rajesh Shrotriya, M.D. (4) Consists of shares options to purchase 919,809 shares of common stock.
2024-04-29 Dr. Shrotriya was appointed to our Board of Directors on January 13, 2021. Prior to joining our company, Dr. Shrotriya served as Chairman of the Board and Chief Executive Officer of Spectrum Pharmaceuticals, Inc.

Data sourced from SEC filings. Last updated: 2025-08-30